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The canonical conformational states occupied
by most ligand-gated ion channels, and many
cell-surface receptors, are the resting, acti-
vated, and desensitized states. While the rest-
ing and activated states of multiple receptors
are well characterized, elaboration of the struc-
tural properties of the desensitized state, a state
that is by definition inactive, has proven diffi-
cult. Here we use electrical, chemical, and
crystallographic experiments on the AMPA-
sensitive GluR2 receptor, defining the confor-
mational rearrangements of the agonist binding
cores that occur upon desensitization of this li-
gand-gated ion channel. These studies demon-
strate that desensitization involves the rupture
of an extensive interface between domain 1 of
2-fold related glutamate-binding core subunits,
compensating for the ca. 21 of domain closure
induced by glutamate binding. The rupture of
the domain 1 interface allows the ion channel
to close and thereby provides a simple explana-
tion to the long-standing question of how ago-
nist binding is decoupled from ion channel gat-
ing upon receptor desensitization.
INTRODUCTION
Chemical communication across cell membranes is com-
monly mediated by ligand-gated ion channels and cell-
surface receptors. In many instances, diffusible ligands
(agonists) bind to the extracellular domain of the receptor,
induce specific conformational changes, and stabilize the
activated state. Once activated, the agonist either unbindsfrom the receptor and the receptor returns to the apo, rest-
ing state (deactivation), or the agonist bound receptor un-
dergoes one or more additional conformational changes
that decouple the action of agonist binding from receptor
activation, i.e., the receptor is desensitized by or insensi-
tive to the activating action of agonist. While there are
a number of receptors for which we have atomic-scale
views of resting and activated states (Armstrong et al.,
2003; Furukawa and Gouaux, 2003; Miyazawa et al.,
2003), we know little about the conformational changes
that occur upon receptor desensitization and the resulting
structure of the desensitized state.
Ionotropic glutamate receptors (iGluRs) are ligand-
gated ion channels activated by the binding of the neuro-
transmitter glutamate. Activation triggers the opening of
cation-permeable channels, thereby transducing a chemi-
cal signal derived from the presynaptic release of gluta-
mate to an electrical signal that results in depolarization
of the postsynaptic cell (for recent reviews, see Dingledine
et al., 1999; Madden, 2002; Mayer, 2006; Mayer and Arm-
strong, 2004; Oswald, 2004). The portion of the iGluRs in-
volved in glutamate binding includes two discontinuous
polypeptide segments, called S1 and S2 (Stern-Bach
et al., 1994), that, when linked together, fold to a two-do-
main or ‘‘clamshell’’-like structure: the S1S2 ligand-bind-
ing core (Armstrong et al., 1998; Kuusinen et al., 1995)
(Figure S1). Structural studies on GluR2 S1S2 have shown
that the ligand-binding domains assemble as a pair of di-
mers in the full-length, tetrameric receptor (Armstrong and
Gouaux, 2000; Sun et al., 2002).
Activation of the GluR2 receptor involves binding of glu-
tamate to the agonist-binding domain clamshell, followed
by closure of the clamshell by approximately 21 (Arm-
strong and Gouaux, 2000). Because the ligand-binding
domains are braced against each other in a back-to-
back fashion, this simple domain closure is transduced
to the ion channel domain, leading to opening of the con-
ductive pore (Sun et al., 2002). Deactivation is simply theCell 127, 85–97, October 6, 2006 ª2006 Elsevier Inc. 85
reverse of this process, i.e., reopening of the clamshell,
closure of the conductive pathway, and release of gluta-
mate. Current understanding of the molecular mechanism
of desensitization, by contrast, is limited to observations
that disruption of the nondesensitized dimer interface, as
exemplified by many GluR2 S1S2 structures (Sun et al.,
2002), modulates the rate and extent of receptor desensi-
tization. We are motivated to map the conformational
changes that occur upon desensitization to understand
how agonist binding is decoupled from ion channel activa-
tion, not only because the GluR2 receptor undergoes de-
sensitization on a millisecond timescale, exhibiting less
than a few percent of the ‘‘peak’’ or nondesensitized cur-
rent at steady state (see for example Horning and Mayer,
2004; Koike et al., 2000; Krampfl et al., 2002) but also be-
cause this rapid decrease in ion channel activity may play
an important role in modulating synaptic currents.
Traditional methods for stabilizing receptors in specific
conformational states include the judicious application of
mutations or the use of small-molecule agonists, antago-
nists, or allosteric modulators. Indeed, such techniques
were crucial in establishing that the domain 1–domain 1
dimer interface in theGluR2 S1S2 crystal structures repre-
sented the nondesensitized state of the receptor (Sun
et al., 2002). By contrast, tools such as sodium thiocya-
nate, which stabilize the desensitized state of AMPA re-
ceptors (Bowie and Smart, 1993; Donevan and Rogawski,
1998), or mutations such as Ser754 to Asp, which desta-
bilize the nondesensitized state (Partin et al., 1996; Sun
et al., 2002), have proven ineffective in stabilizing the de-
sensitized state to a sufficient extent to allow for detailed
biophysical and crystallographic characterization. Here
we apply disparate experimental approaches, including
chemical modification, electrophysiology, and crystallog-
raphy, to independently probe the conformational rear-
rangements of the extracellular glutamate-binding core
subunits that accompany receptor desensitization.
RESULTS
Protein Constructs
To minimize undesired, nonspecific reactions between
thiol-directed chemical-modifying reagents and endoge-
nous cysteine residues, we modified the full-length rat
GluR2 (flip) (Sommer et al., 1990). We first deleted the
entire amino-terminal domain (ATD). Justification for this
deletion comes from studies showing that GluR2 recep-
tors in which the ATD has been genetically removed retain
ligand-binding affinities, agonist potencies, and kinetic
properties similar to the wild-type receptor (Horning and
Mayer, 2004; Pasternack et al., 2002). Second, we mu-
tated native, free cysteine residues in the S1S2 ligand-
binding core (C425A, C436V) and the transmembrane do-
mains of this ATD-deleted construct to either isosteric
amino acids or to noncysteine amino acids present at
equivalent positions in related glutamate receptors
(C528Y, C589S). Of the remaining cysteine residues, two
form a disulfide bond within S1S2 (C718/C773) and the86 Cell 127, 85–97, October 6, 2006 ª2006 Elsevier Inc.third (C815) is intracellular. We refer to the ATD-deleted re-
ceptor with the three native cysteines as the GluR2 DATD
construct, a construct that has a glutamate dose-re-
sponse curve, measured by two-electrode voltage-clamp
(TEVC), similar to the wild-type receptor (Figure S1). The
GluR2 S1S2 ligand-binding core constructs contain all
native cysteine residues.
Dimer Interface Becomes More Accessible
upon Desensitization
The nondesensitized state of the GluR2 receptor is stabi-
lized by extensive contacts between interdigitated resi-
dues at the 2-fold related domain 1–domain 1 interface
of the S1S2 ligand-binding core (Horning and Mayer,
2004; Sun et al., 2002). Many of these residues are largely
inaccessible to bulk solvent, as judged by atomic struc-
tures (Sun et al., 2002). One such residue is Glu 486, which
makes a critical salt link to Lys493 in the 2-fold related
subunit (Armstrong and Gouaux, 2000; Horning and
Mayer, 2004; Sun et al., 2002) (Figure 1A). To probe
whether sites within the dimer interface become more ac-
cessible upon desensitization, we examined the rate of
modification of the Glu486 to Cys mutant (E486C) using
sodium (2-sulfonatoethyl)methane thiosulfonate (MTSES)
(Akabas et al., 1992, 1994). Derivatization of E486C with
MTSES generates an anionic side chain that is larger
than glutamate. Because previous studies have shown
that even conservative mutation of residues located within
the dimer interface generally increases the extent of re-
ceptor desensitization (Horning and Mayer, 2004; Sun
et al., 2002), we hypothesized that modification of
E486C with MTSES would also increase the extent of re-
ceptor desensitization, thereby decreasing the magnitude
of ‘‘steady-state’’ or ‘‘plateau’’ current, as measured by
TEVC in the presence of saturating concentrations of
glutamate.
To probe the cysteine accessibility of E486C under con-
ditions that populate either the nondesensitized or desen-
sitized states of the GluR2 receptor, we measured appar-
ent reaction rates with MTSES under three different
conditions: (1) 10 mM 6,7-dinitro-2,3-quinoxalinedione
(DNQX), a competitive antagonist that will stabilize the
closed-channel, nondesensitized state (Honore´ et al.,
1988); (2) 1 mM glutamate, a full agonist that will populate
the closed-channel, desensitized state; and (3) 1 mM glu-
tamate and 100 mMcyclothiazide (CTZ) (Partin et al., 1993;
Yamada and Tang, 1993), a combination of agonist and
modulator that will stabilize the open channel, nondesen-
sitized state (Figures 1B–1D).
We found that MTSES modification of E486C is slow in
the presence of either DNQX or glutamate and CTZ, with
second-order rate constants of 101 and 15.9 M1s1, re-
spectively (Figure 1E). We suggest that the slow rate of re-
action of MTSES in the presence of cyclothiazide is due to
the fact that cyclothiazide stabilizes the dimer interface in
a compact conformation, rendering E486C relatively inac-
cessible to modification. It is possible that CTZ inhibited
the MTSES reaction via direct steric effects because
Figure 1. MTSES Modification of E486C
in Closed, Open, and Desensitized States
(A) Ribbon diagram and solvent-accessible
surface of the GluR2 S1S2 dimer viewed per-
pendicular to the 2-fold symmetry axis. The im-
age is cut away to show the salt bridge be-
tween Glu486 (red) and Lys493 (blue), which
is buried in the middle of the dimer interface.
(B) Sample records for closed-state MTSES
modification. The reaction protocol consisted
of alternating between 5 s applications of 1
mM MTSES plus 10 mM DNQX and test pulses
of 1 mM glutamate.
(C) Sample records for desensitized-state
modification. The rate of MTSES modification
in the desensitized state was measured by
coapplication of 50 mM MTSES in the contin-
ued presence of 1 mM glutamate.
(D) Sample records for activated-state modifi-
cation. The rate of MTSES modification in the
open-channel state was measured by coappli-
cation of 1 mM MTSES in the continued pres-
ence of 1 mM glutamate and 100 mM CTZ.
(E) Time constants for MTSES modification in
glutamate and glutamate plus CTZ conditions
were calculated by directly fitting the current
decline recorded during application of MTSES
to a single exponential function. The time con-
stant for closed-state modification was cal-
culated by plotting cumulative time in MTSES
versus I/Io and fitting the points to a single
exponential function. The second order rate
constant was calculated by dividing the inverse
of the time constant by the MTSES concentra-
tion. MTSES reaction rates were 101 ± 3.8,
3312 ± 174, 15.9 ± 3.2 M1s1 for closed-, de-
sensitized-, and open-channel states, respec-
tively (n = 5).
All errors are SEM.modeling the E486C cysteine into the GluR2/CTZ cocrys-
tal structure shows that the cysteine sulfhydryl is 6 A˚
from CTZ (Sun et al., 2002).
In contrast to the slow MTSES reaction rates measured
under the glutamate/CTZ and DNQX conditions, the
MTSES reaction rate in the presence of glutamate was
3312 M1s1, 33 times faster than in the presence of
DNQX (Figure 1E). The fact that the rate of MTSES modi-
fication of E486C is at least 33-fold faster under condi-
tions that populate the desensitized state than it is under
conditions that populate the nondesensitized state sup-
ports two important conclusions. First, the slower reaction
rate in the absence of glutamate suggests that the dimer
interface is compact or occluded in the resting state,
a conclusion that has, until now, been speculative. Sec-
ond, the faster reaction rate of E486C under conditions
that favor the desensitized state suggests that the thiol
moiety ismore accessible in the desensitized state. There-
fore, we suggest that the domain 1–domain 1 dimer inter-
face ‘‘opens up’’ and is more accessible upon transition
from the non desensitized state to the desensitized state.Indeed, similar MTSES experiments on K493C, a residue
that forms a salt bridge with E486 across the dimer inter-
face in the nondesensitized conformation, yield rates of
reaction of 10, 34.9, and 3016M1 s1 in the closed-chan-
nel, nondesensitized state (+DNQX), the open-channel,
nondesensitized state (+glutamate/CTZ), and the closed-
channel, desensitized state (+glutamate), respectively,
thereby reinforcing the conclusion that residues in the do-
main 1–domain 1 dimer interface become more accessi-
ble upon receptor desensitization.
Measurements of Domain–Domain Separation
To measure the separation distance between residues in
the dimer interface upon desensitization, we carried out
a series of chemical modification experiments using
thiol-directed bifunctional crosslinkers of four different
lengths, together with three single cysteine mutants of
the GluR2 DATD construct (Figures 2A and 2B). We hy-
pothesized that the shorter crosslinkers will block desen-
sitization because they will restrain the domain 1–domain
1 interface to a nondesensitized or nondesensitized-likeCell 127, 85–97, October 6, 2006 ª2006 Elsevier Inc. 87
Figure 2. Bifunctional Crosslinking of Selected Dimer Interface Cysteine Mutants
(A) Ribbon diagram of the wild-type glutamate-bound structure with the locations of the sites selected for crosslinking demarcated with yellow
spheres. The artificial linkers that replace the ion channel domains are depicted as red spheres.
(B) Molecular structure and corresponding lengths of the four bifunctional MTS crosslinkers used in this study.
(C) Sample records before (black) and after (red) exposure to the MTS crosslinker. DATD currents are not potentiated after 5 min of exposure to 0.3
mM of any of the MTS crosslinkers. G739C currents are potentiated by all four of crosslinkers after 2 min exposure to 1 mM crosslinkers. G743C
currents are potentiated after 5 min exposure to 0.3 mM MTS3, MTS6, and MTS11, but not MTS17. K493C currents are potentiated following
7 min exposure to 0.3 mM MTS3 and MTS6, but not MTS11.
(D) Graph of mean current change (Ipost-MTS/Ipre-MTS) for the control and mutant constructs (nR 3). N.D.: Not Determined.
All errors are SEM.conformation, while the longer crosslinkers will have no
effect on the extent of receptor desensitization because
they will not be ‘‘pulled’’ to their fully extended conforma-
tion upon receptor desensitization. In other words, the
shorter crosslinkers will potentiate glutamate-induced
equilibrium currents, while the crosslinkers that are long
enough to span the desensitized conformation will not
potentiate equilibrium currents.
Near the ‘‘top’’ of the dimer interface is G739C, and all
four crosslinkers potentiated glutamate-induced currents
(Figure 2C). In the case of G743C, the three shortest
crosslinkers potentiated equilibrium currents. However,
following reaction with the longest crosslinker, the gluta-
mate-induced equilibrium currents were actually smaller
than the currents observed prior to modification. At
K493C, the two shortest crosslinkers potentiated equilib-88 Cell 127, 85–97, October 6, 2006 ª2006 Elsevier Inc.rium currents, but the third shortest (18 A˚) did not potenti-
ate currents (Figure 2C; Table S1). The extent of cross-
linker-induced potentiation for the three cysteine
mutants ranged from 7- to 33-fold with K493C exhibiting
the greatest effect from crosslinking andG743C exhibiting
the least (Figure 2D).
The crosslinking data, together with the crystal struc-
ture of the nondesensitized state, allow us to estimate
the distance that residues 739, 743, and 493 move upon
desensitization. Using the GluR2 S1S2-L483Y dimer as
a model for the nondesensitized state (Sun et al., 2002),
we modeled cysteines into positions 739, 743, and 493,
choosing side chain rotomer conformations that mini-
mized the sulfur to sulfur distances. Subtraction of the ex-
tended length of the longest potentiating crosslinker from
the distance between the 2-fold related cysteine sulfur
Figure 3. S729C Forms a Spontaneous Disulfide Bond Locking the Receptor in a Nonconducting Channel State
(A) Sample records for S729C before and after 5 min exposure to 2 mM DTT.
(B) Whole-cell western blots of uninjected oocytes (un) and oocytes injected with RNA encoding the parent DATD, K493C, S729C/L483Y, and S729C
constructs, run under nonreducing and reducing (+100 mM b-mercaptoethanol) conditions. The equivalent of 1/2 an oocyte was loaded per lane.
Whereas the S729C runs as mostly dimer under nonreducing conditions, the relative proportion of dimer is decreased in the context of the L483Y
substitution.
(C) Plot of fold change in current following 5min exposure to 2mMDTT. Of the nine single-cysteine mutants tested, three (I664C, G725C, and S729C)
had larger currents after reduction. The current change measured for the remaining cysteine mutants following DTT treatment was similar to that of
control oocytes (DATD) (10%–30% attenuation) and was indistinguishable from rundown (nR 4 for all constructs). Note the different scale for S729C.
(D) Mapping of DTT sensitivity to the S1S2 surface. Blue patches are DTT-insensitive positions, orange patches aremildly DTT-sensitive sites, and the
red patch is S729C. Residues in panels (C) and (D) are color-coded similarly.
All errors are SEM.atoms yields a lower bound for the distance change ac-
companying desensitization (Table S1). Specifically, resi-
dues 739, 743, and 493 move more than 13.9, 9.1, and
6.9 A˚ apart, respectively, upon desensitization. Using the
lengths of the shortest nonpotentiating crosslinkers we
estimate that the distance change upon desensitization
for residues 743 and 493 is less than 16.2 and 12.4 A˚, re-
spectively. These calculations reveal a pattern in which
the largest movements occur at the ‘‘top’’ of the dimer in-
terface and the smallest movements take place near the
‘‘bottom.’’
How do we know that the bifunctional crosslinkers have
reacted with the desired cysteine residues and are thus
faithfully measuring the conformational changes that oc-
cur upon desensitization? Using chemical and electro-
physiological methods we certainly cannot prove that
the crosslinkers are faithful reporters. Thus, to probe the
conformational changes occurring upon desensitization
using completely different approaches, we examinedadditional single cysteinemutants using electrophysiolog-
ical and crystallographic methods.
Stabilization of the Desensitized State
In the course of analyzing the gating properties of cysteine
mutants within or adjacent to the dimer interface by TEVC,
we encountered a mutant, S729C, that exhibited unusu-
ally small currents (24 nA ± 12 nA; n = 20). Neither increas-
ing the dose of injected cRNA nor increasing the duration
of oocyte incubation between cRNA injection and TEVC
recording significantly increased the currents elicited by
glutamate application. Surprisingly, the current magnitude
was increased 56-fold, to 1–2 mA, following a 5 min ex-
posure to 2 mM dithiothreitol (DTT) (Figure 3A), while the
same DTT application had no effect on the parent GluR2
DATD construct. Analysis of oocytes injected with
S729C cRNA by SDS-PAGE and western blotting demon-
strated that under nonreducing conditions the majority of
the protein migrated at a position that was consistent withCell 127, 85–97, October 6, 2006 ª2006 Elsevier Inc. 89
a dimer of GluR2 DATD subunits. By contrast, both GluR2
DATD and GluR2 DATD K493C ran as monomers under
nonreducing conditions (Figure 3B). These electrophysio-
logical and biochemical results support the conclusion
that S729C receptors spontaneously form a disulfide
bond and that the non-native disulfide bond greatly re-
duces glutamate-induced equilibrium currents.
Spontaneous disulfide bond formation by S729C was
a particularly remarkable result given that in the L483Y
crystal structure the hydroxyl groups of Ser729 are lo-
cated >12 A˚ apart, much too large a distance to yield
the efficiency of disulfide bonding observed in our exper-
iment. For comparison, the distance between cysteines
modeled into position K493C was much less, only 5.6
A˚, but we observed no spontaneous disulfide bond forma-
tion with this mutant (Figure 3B). These observations led
us to hypothesize that under ambient oxidizing conditions,
subunits of the GluR2 DATD S729C receptor were held to-
gether by a disulfide bond in an interface not observed in
previous crystal structures.
To probe the specificity of spontaneous disulfide bond
formation between adjacent subunits by way of DTT sen-
sitivity, we examined eight additional cysteine mutants.
Seven of the mutation sites were located on the S1S2 sur-
face within 20 A˚ of S729. The eighth site was located in
loop 2. Mutants were tested for DTT sensitivity bymeasur-
ing currents before and after a 5 min exposure to 2 mM
DTT (Figure 3C). Six of themutants exhibited no significant
change in glutamate-induced equilibrium currents follow-
ing DTT exposure. For two mutants, I664C and G725C,
DTT application resulted in potentiation of 3.6- and 2.8-
fold, respectively. Mapping the effects of DTT modulation
to the S1S2 surface showed that the DTT-sensitive pheno-
type is localized to a domain 2 face that contains the be-
ginning of the second interdomain b strand (G725 and
S729) and the loop connecting helices F and G (I664)
(Figure 3D).
How does the S729C mutation diminish glutamate-in-
duced ion channel activity? Does the mutant stabilize
a resting (inactive) state or a desensitized-like state? If
S729C receptors were trapped in the resting state or if di-
sulfide bonding compromised the conformational change
leading to receptor activation (i.e., domain closure), then
we would expect the receptors to have an increased ago-
nist dissociation constant (KD) or agonist potency (EC50)
for ligands such as glutamate or AMPA. To directly deter-
mine KD values, we carried out
3H-AMPA binding assays.
Binding measurements were performed under nonreduc-
ing conditions on membranes prepared from HEK293
cells expressing the parent DATD and S729C constructs
in which green fluorescent protein (GFP) was fused to
receptors’ C termini. Fluorescence measurements and
western blots showed that the mutant protein was ex-
pressed at substantially lower levels than the DATD con-
trol and thus accounted for the smaller Bmax value for
S729C relative to DATD (Figure S2). Nonetheless, we
found that S729C retained high-affinity 3H-AMPA binding;
the KD values for S729C and DATDwere 27.2 nM and 36.290 Cell 127, 85–97, October 6, 2006 ª2006 Elsevier Inc.nM, respectively (Figure S2). These values are representa-
tive of agonist binding to the desensitized state, as shown
previously from measurements carried out in the absence
or presence of CTZ (Hall et al., 1993; Kessler et al., 1996).
To verify that the 3H-AMPA KD measured for nonreduced
S729C did not simply reflect binding to a subpopulation of
nondisulfide bonded receptors, we measured total 3H-
AMPA binding counts forDATD and S729C in the absence
and presence of 2 mM DTT. This concentration of DTT
is sufficient to reduce the disulfide bond for >99% of
S729C receptors (data not shown). Inclusion of 2 mM
DTT in the binding buffer did not change the total counts
measured for S729C, indicating that disulfide bonding
does not prevent high-affinity AMPA binding (Figure S2).
Evaluation of whether the S729Cmutation altered gluta-
mate potency (EC50) in a TEVC experiment was compli-
cated by the fact that the glutamate-induced currents
prior to reduction were small (i.e., 20 nA) and that following
reduction the currents were subject to rapid rundown.
Thus it was not possible to accurately determine a gluta-
mate dose-response curve. To circumvent these prob-
lems we made the S729H mutant, with the hope of gener-
ating a variant of S729C in which the currents were larger
and where the addition of Zn+2 would mimic the S729C di-
sulfide bond. Unfortunately, S729H was insensitive to
zinc, perhaps because the histidine residues were im-
properly oriented for zinc binding. However, introduction
of a histidine at G725, a site where a cysteine resulted in
substantial DTT potentiation (Figure 3), yielded a mutant
where glutamate-induced currents were inhibited by zinc
to a substantially greater extent than the parent DATD
construct (data not shown).
To determine the effect of zinc on agonist-induced acti-
vation of the receptor, we employed the glutamate analog,
quisqualate (Jin et al., 2002) (Figures 4A and 4B). Because
the apparent affinity (EC50) for quisqualate is ca. 20-fold
higher than that of glutamate, we were able to work at
agonist concentrations that did not result in significant
sequestration of zinc. With this reversible systemwemea-
sured the agonist potency for G725H in the presence and
absence of zinc. The quisqualate EC50 values for G725H
were 1.3 and 1.9 mM in the absence and presence of
100 mM zinc, respectively (Figure 4C). These dose-re-
sponse data indicate that tethering domain 2 across di-
mers does not disrupt the activation process, suggesting
that zinc inhibits G725H via a noncompetitive mechanism,
perhaps by stabilization of a desensitized-like conforma-
tion. By analogy, we hypothesize that, under oxidizing
conditions, S729C and G725C also stabilize a desensi-
tized-like state.
If the S729C mutant is trapped in a desensitized or de-
sensitized-like state, then incorporation of an additional
mutation that stabilizes the nondesensitized state should
disfavor formation of the intersubunit S729C disulfide
bond, and this effect should reflect itself in electrophysiol-
ogy and western blot assays. We chose the L483Y muta-
tion because it profoundly stabilizes the nondesensitized
state (Stern-Bach et al., 1998). Indeed, we found that
Figure 4. G725H Currents Are Inhibited
by Zinc
(A) Representative records showing dose-
dependent zinc inhibition of 30 mM quisqua-
late-elicited currents at DATD and G725H
receptors.
(B) Degree of inhibition of 30 mM quisqualate
currents in the presence of 1 mM zinc. Re-
sponses for each construct were normalized
to responses measured in the absence of
zinc. Degrees of zinc inhibition are 0.754 ±
0.034 and 0.129 ± 0.015 for DATD and
G725H, respectively.
(C) Quisqualate dose-response curves mea-
sured in the absence (squares) and presence
(circles) of 100 mM zinc. The quisqualate EC50
values (Hill coefficient) were 1.25 ± 0.05 mM
(1.18) and 1.93 ± 0.08 mM (0.95) in the absence
and presence of zinc, respectively (n = 4).
All errors are SEM.oocytes expressing GluR2 DATD L483Y/S729C receptors
had large glutamate-induced currents. The increased cur-
rent size was not entirely due to an alleviation of desensi-
tization by the L483Y mutation because currents from un-
reduced S729C recorded in the presence of 100 mM CTZ
remained small, i.e., in the context of the S729C mutation
the extent of CTZ potentiation was much smaller (>10-
fold) than that for the wild-type receptor (Figure 5A). The
degree of DTT potentiation was significantly reduced in
L483Y/S729C receptors; the double mutant exhibited
only20-fold current potentiation following DTT reduction
(Figure 5B). Most importantly, in western blot analysis, the
intensity of the L483Y/S729C dimer band was substan-
tially decreased relative to S729C, and there was a con-
comitant increase in monomer band intensity (Figure 3B).
These results support the conclusion that a disulfide bond
in S729C receptors traps a dimer conformation distinct
from that which is stabilized by the L483Y mutation, and
the conformation stabilized by S729C may be similar to
a desensitized state.
The S1S2 S729C Crystal Structure Depicts
a ‘‘Relaxed’’ Dimer Conformation
The presence of the S729C mutation within the S1S2 re-
gion of the GluR2 DATD receptor raised the possibility
that we could make the mutation in the context of the
readily crystallized GluR2 S1S2 ligand-binding core and
determine the structure of the disulfide-linked dimer byX-ray crystallography. Crystals of the GluR2 S1S2
S729C dimer formed readily in the presence of glutamate
and diffracted to 2.3 A˚. The structure was determined by
molecular replacement using the S1S2-glutamate proto-
mer as a search probe. Difference Fourier maps (>4s)
revealed unambiguous density for a disulfide bridge be-
tween the cysteine residues at position 729 (Figure 6A).
The S1S2 S729C crystal structure contains two proto-
mers in the asymmetric unit, arranged around an approx-
imate 2-fold axis of molecular symmetry (Figure 6A).
Superimposing the S1S2 S729C dimer on the S1S2
L483Y dimer, which is a model for the nondesensitized
state, revealed a dramatic change in the relative orienta-
tion of protomers (Figures 6B and 6C). In the L483Y dimer,
the dimer interface is anchored by residues from domain
1, allowing domain 2 to move upon agonist binding. In
the ‘‘relaxed’’ S729C dimer, all interactions that stabilize
the L483Y dimer interface are disrupted. For example,
the a carbons of Gly739, Gly743, and Lys493 are located
13.5, 12.1, and 9.2 A˚ farther apart, respectively, than in the
L483Y dimer (Figure 6D). The separation of residues in the
domain 1 interface is concomitant with an increased prox-
imity of sites within domain 2. The pseudo 2-fold related
729 a carbon atoms were separated by 13 A˚ in the
L483Y structure and are now 6.6 A˚ apart in S729C. Most
importantly, residues in the S1S2 ‘‘linker,’’ which replaces
the ion channel membrane domains, move closer by 10
A˚ relative to their positions in the L483Y-AMPA crystalCell 127, 85–97, October 6, 2006 ª2006 Elsevier Inc. 91
structure, suggesting a mechanism for ion channel clo-
sure upon receptor desensitization (Figure 6D).
Unlike the L483Y dimer, the S1S2 S729C dimer devi-
ates by12 from 2-fold symmetry, resulting in a single in-
terface created by interactions between residues in the
loop between helices F and G in one subunit (A) and helix
K of the adjacent protomer (B) (Figure 6E). Although dimer
formation buries 480 A˚2 of solvent accessible surface
area on each subunit, the interface is composed of only
three hydrogen bonds and a salt bridge, in addition to
the disulfide bond. Two hydrogen bonds are formed be-
tween Asn764 (A) and the backbone carbonyl and amide
atoms of residues Lys663 (B) and Ala665 (B), respectively.
The third hydrogen bond is between Asp760 (A) and the
backbone amide of Lys663 (B). The salt link occurs be-
tween Arg661 (B) and Glu755 (A). Compared to the inter-
face observed in the L483Y structures, the S729C inter-
face contains relatively few interactions and buries
600 A˚2 less surface area.
Accompanying the large change in protomer orientation
is a small change in the conformation of individual proto-
mers. Superposition of S729C protomers with the wild-
type glutamate bound structure yields root mean squared
deviation (rmsd) values of 0.6 and 0.7 A˚ for protomers A
and B, respectively. The rmsd values are elevated be-
cause the lobes of the S729C protomers are 4 more
closed than in the wild-type structure. Several additional
electrostatic interactions across the binding cleft stabilize
Figure 5. The L483Y Mutation Increases Steady-State Cur-
rent and Decreases DTT Potentiation in S729C Background
(A) Maximal glutamate-induced currents from S729C and L483Y/
S729C oocytes and from S729C oocytes in 100 mM CTZ. Oocytes
were injected with 2.5 ng of each construct and currents were mea-
sured 3 days post-injection. Mean Imax values are 0.02 ± 0.01 mA (n =
20), 1.30 ± 0.57 mA (n = 7), and 0.20 ± 0.05 mA (n = 3) for S729C,
L483Y/S729C, and S729C + CTZ, respectively.
(B) Mean fold potentiation following 5min exposure to 2mMDTT is de-
creased for L483Y/S729C relative to S729C. The mean fold potentia-
tion is 55.5 ± 12.8 (n = 9) and 20.7 ± 3.6 (n = 5) for S729C and
L483Y/S729C, respectively.
All errors are SEM.92 Cell 127, 85–97, October 6, 2006 ª2006 Elsevier Inc.this new conformation. The backbone amide of Gly451
forms a hydrogen bond with the side chain hydroxyl of
Ser652, and the side chain of Lys449 interacts with both
Ser652 and Arg684.
To test the specificity of the relaxed dimer configuration,
we determined the crystal structure of the GluR2 S1S2
G725C dimer, also bound to glutamate. The S1S2
G725C asymmetric unit contains two relaxed dimers,
both with clear electron density for the disulfide bond be-
tween G725C residues on adjacent protomers. The
S729C and G725C S1S2 dimers are similar in structure
with rmsd values of 1.5 A˚ for superposition of all Ca
atoms. Nevertheless, the domain 1–domain 1 interface is
more separated in the G725C structures, presumably be-
cause the location of the tethering disulfide bond is simply
different from that of S729C (Figure 6F).
DISCUSSION
It is an unfortunate paradox that the most energetically
stable state of glutamate receptors, the desensitized con-
formation, has also proven the most resistant to structural
investigation. There are nowwell over 50 crystal structures
of glutamate receptor ligand-binding cores, including sev-
eral from each of the three receptor subtypes as well as
a bacterial homolog (Mayer, 2005; Mayer and Armstrong,
2004). In most of these structures the protomers associate
in a similar manner, forming a 2-fold symmetric dimer that
is held together by interactions formed mainly between
residues in domain 1. However, there is little knowledge
of the structure of the desensitized state.
S729C Is Locked in a Desensitized State
How do we know that S729C traps a desensitized confor-
mation of the receptor? The extremely small currents eli-
cited from unreduced S729C oocytes and the 56-fold
potentiation following reduction suggested that the disul-
fide bond constrains the receptor to a closed-channel
conformation, but they do not tell us whether the state is
similar to a resting or a desensitized state. However, these
states can be distinguished on the basis of their agonist-
binding affinities; the calculated glutamate affinity for the
desensitized state is 4000-fold higher affinity than the
resting state (Robert et al., 2005). We find that unreduced
S729C binds 3H-AMPA with an affinity similar to wild-type
and that binding counts do not increase following treat-
ment with reducing agent. Furthermore, in the G725Hmu-
tant, quisqualate potency is unchanged by the presence
of 100 mM zinc even though this concentration of ions in-
hibits receptor currents by 50%. These results indicate
that tethering together sites within domain 2 does not
compromise the ability of the receptor to bind agonists,
thereby demonstrating that S729C is not locked in a rest-
ing state.
Support for the notion that S729C traps a desensitized
state comes from the L483Y/S729C double mutant. In-
troduction of the L483Y mutation (Stern-Bach et al.,
1998) into the S729C background reduces the propensity
Figure 6. GluR2 S1S2 S729C Crystal Structure Reveals a ‘‘Relaxed’’ Dimer
(A) S729C structure viewed along pseudo 2-fold showing deviation from 2-fold symmetry and density for disulfide bond.
(B) Superposition of protomer A from L483Y (gray) and S729C structures, viewed approximately perpendicular to pseudo 2-fold axis. TheGly-Thr (GT)
linker that replaces the ion channel domain is shown with red (S729C) or pink (L483Y) spheres.
(C) Same molecules as in (B) viewed down pseudo 2-fold axis.
(D) Same view as (B) showing relative movements that accompany receptor desensitization. Ca positions are shown for residues 739 and 729 and the
glycine of the GT linker, with residues for the L483Y dimer in lighter shades.
(E) The ‘‘BA’’ interface (see also A).
(F) Superposition of one protomer from the dimers of the L483Y (gray), S729C (blue), and G725C (pink, brown) structures.for spontaneous disulfide formation as judged by SDS-
PAGE and decreases the extent of DTT-induced current
potentiation. Strictly speaking, the fact that a mutation
that preferentially stabilizes the nondesensitized state in-
hibits spontaneous disulfide bond formation only suggests
that the disulfide bonded state is different from the nonde-sensitized state. If the S729C, G725C, and G725H muta-
tions stabilize a desensitized state, then one would predict
that the presence of Zn2+ would slow the rate at which
the GluR2 DATD G725H mutant recovers from desen-
sitization. A slowing of recovery from desensitization
in the presence of zinc would indicate that, uponCell 127, 85–97, October 6, 2006 ª2006 Elsevier Inc. 93
Figure 7. Mechanism of Activation and
Desensitization
(A) Correlation between length of the longest
potentiating crosslinker and the average
change in sulfur to sulfur separation between
mutants in the L483Y (nondesensitized) and
S729C (desensitized) states (see also Figure 2;
Table S1).
(B) Shown are two subunits of the tetramer,
with the ATD omitted and the transmembrane
domains represented by a single green cylin-
der. Glutamate binds to the receptor and do-
main closure occurs, with two possible out-
comes: either the D1–D1 interface remains
fixed and the domain closure is translated into
ion activation, or the D1–D1 interface ruptures
and the ion channel closes, leading to the de-
sensitized state.
All errors are SEM.desensitization, domain 2of each subunit in a dimer comes
close enough together to form a histidine–zinc bridge.
S729C and G725C Structures Depict a Desensitized
S1S2 Dimer
How do we know that the crystal structures are represen-
tative of the native desensitized conformation? Perhaps
the strongest evidence that the S729C and G725C struc-
tures define a conformation representative of the desensi-
tized state comes from the agreement between the dis-
tances obtained from the crosslinking data and those
measured in the crystal structures. To gauge these simi-
larities we modeled cysteines into the S729C and
G725C crystal structures at positions 493, 739, and 743
using side chain rotomer conformations that minimized
the distance separating the cysteines across the dimer
interface. Plotting the mean of these distances versus
the length of the longest potentiating crosslinkers for the
three tested positions shows a striking correlation be-
tween the crosslinking data and the crystal structures
(Figure 7A).
The resemblance between the native desensitized state
and the S729C and G725C crystal structures is also sup-94 Cell 127, 85–97, October 6, 2006 ª2006 Elsevier Inc.ported by several reports in the literature. First, kinetic
studies conclude that in the desensitized state the binding
cleft conformations of the two subunits in an AMPA recep-
tor dimer differ, with one subunit being stabilized in
a closed-cleft conformation exhibiting a slower rate of glu-
tamate dissociation (Robert and Howe, 2003). Indeed, we
find that the S729C and G725C dimers deviate signifi-
cantly from perfect 2-fold symmetry, and this deviation
from 2-fold symmetry might give rise to differences in
the rate of glutamate dissociation. Second, it has recently
been shown that the ATD orientation in AMPA receptors
changes substantially upon desensitization (Nakagawa
et al., 2005). Movement of the ATDs is simply the conse-
quence of the rigid body separation of domain 1 on each
subunit. Third, a mutational analysis of the entire length
of helix J concluded that no sites in this region contribute
to stabilization of the desensitized conformation (Horning
and Mayer, 2004). Residues in helix J, which participate in
many crucial interactions in the nondesensitized state,
make no interprotomer contacts in the S1S2 S729C and
G725C crystal structures.
Although the overall trends between the functional and
structural data are consistent, we are not under the illusion
Cell 127, 85–97, October 6, 2006 ª2006 Elsevier Inc. 95that the S729C and G725C crystal structures are replicas
of the native desensitized state. Indeed, there are modest
inconsistencies in our data that suggest that the native de-
sensitized conformation differs in subtle ways from our
structures. For instance, the longest crosslinker is 25.1 A˚
yet it potentiates G739C currents even though the mean
distance between modeled cysteine sulfhydryls in the
S729C and G725C crystal structures is23.0 A˚. Likewise,
K493C currents are potentiated by the 12.5 A˚ crosslinker,
but themean sulfhydryl separation is 11.6 A˚. On thewhole,
these differences are smaller than the overall conforma-
tional change occurring upon desensitization and likely
within the uncertainty of our measurements. At present
we do not understand why currents recorded from the
I664C mutant are potentiated 3-fold following DTT re-
duction. In the S1S2 S729C and G725C crystal structures
the a carbons of residue 664 are separated by 32 A˚.
Perhaps I664 is located at a dimer–dimer interface and
the I664C mutant forms inter- rather than intradimer
crosslinks.
Mechanism of Desensitization
GluR2 desensitizes rapidly (t4.2–7.9ms) and profoundly
(98.5%) in the continued presence of glutamate (Horning
and Mayer, 2004; Robert et al., 2005). The large prefer-
ence for the desensitized conformation at steady state in-
dicates the presence of a highly stable receptor conforma-
tion. However, the interface observed in the S729C and
G725C dimers is relatively small, containing just a few hy-
drogen bonds and one salt bridge. This observation, com-
bined with the fact that desensitized-like conformations of
GluR2 S1S2 do not predominate in either solution or the
crystal lattice, suggest that the interface seen in the
G725C and S729C dimers makes a minor contribution to
the overall stability of the desensitized state. We further
suggest that the S1S2 portion of the receptor does not
participate in any significantly stabilizing interprotomer
interactions in the desensitized conformation. Instead we
propose that the stability of the desensitized state is deter-
mined by interactions holding the S1S2-binding core in
a closed-cleft conformation, together with interactions be-
tween juxta-membrane and transmembrane domains
(Ren et al., 2003; Yelshansky et al., 2004). Indeed, the re-
lationship between agonist potency and occupancy of the
desensitized state was recently demonstrated with a se-
ries of GluR2 mutants at position 686, a site which makes
an important interdomain hydrogen bond in the wild-type
GluR2 structures (Robert et al., 2005). Robert et al. (2005)
found that decreased glutamate potency correlates with
both an increase in steady-state current and with faster
rates of recovery from desensitization. This indicates
that the ability of the ligand-binding core to remain tightly
closed is an important determinant of desensitized state
stability, a conclusion in harmony with crystallographic
and electrophysiological studies on GluR2 and 5-
substituted willardiine derivatives (Jin et al., 2003).
The driving force for desensitization and subsequent
channel closure necessarily originates in the ligand-bind-ing domain. Upon binding of glutamate, the clamshell
closes and one of two routes is taken (Figure 7B). Either
the dimer interface remains intact and the ion channel
opens, or the dimer interface disengages and the receptor
enters the desensitized state. Receptors that enter the
open-channel state do so only briefly as the closed-bind-
ing domain/open-channel conformation is high energy.
After channel opening, the dimer interface of these recep-
tors also disengages and they, too, enter the desensitized
state. We propose that dimer disengagement involves
a6–13 A˚ separation of the domain 1–domain 1 interface,
with regions at the ‘‘top’’ of the dimer separating the most
and regions near the ‘‘middle’’ of the dimer separating the
least. As a consequence of this movement, regions in do-
main 2, particularly the beginning of the second interdo-
main b strand, are brought close together. The cysteine
residues we engineered into this b strand (G725C,
S729C) spontaneously form a disulfide bond, locking the
receptor in the desensitized state. The crystal structures
of these mutants show that dimer rearrangement brings
the linker regions, which replace the ion channel domain
in the S1S2 construct, 10 A˚ closer together relative to
their positions in the L483Y crystal structure, demonstrat-
ing that dimer rearrangement neutralizes binding-domain
closure by allowing the linker regions to rotate back into
close proximity, thereby closing the ion channel gate.
EXPERIMENTAL PROCEDURES
Molecular Biology
The rat GluR2-flip gene (Gly at R/G editing site) was used for the elec-
trophysiology experiments. In the DATD construct, the S1 segment of
the mature protein begins at Ser382. This construct contains the wild-
type GluR2 signal sequence linked to S1 by a three residue linker (Ala-
Met-Gly). All point mutations were incorporated by PCR, followed by
DNA sequencing of the entire gene. For the C-terminal GFP fusion con-
structs, the DATD and S729C genes were amplified and cloned into
pcDNA5 (Invitrogen).
Electrophysiology
Xenopusoocyte preparation, injection, and recordingswere carried out
as previously described (Armstrong et al., 2003). Methanethiosulfonate
reagents (Toronto Research Chemicals) were prepared in either water
(MTSES) or DMSO (crosslinkers). Stocks were aliquoted, frozen imme-
diately in liquid nitrogen, stored at80C, and used within 10 min after
thawing. Data were acquired using Pulse (Heka) and processed in Igor
(Wavemetrics) and Kaleidograph. Data are presented as mean ± SEM.
3H AMPA Binding
HEK293 cells were stably transfected with C-terminal GFP fusions of
the DATD and S729C constructs. Cells were grown in 15 cm dishes,
induced with tetracycline at 70%–80% confluency, and harvested
24–48 hr post-induction. The cell pellet was resuspended in 400 ml
PBS with protease inhibitors using a glass homogenizer. Membranes
were pelleted by centrifugation at 40,000 rpm for 15 min at 4C. This
washing process was repeated twice, with the final resuspension car-
ried out in AMPA binding buffer (ABB-30 mM Tris, pH 7.4, 100 mM
KSCN, 2.5 mM CaCl2). For comparative quantification of control and
mutant protein expression levels, a 10 ml aliquot of membranes was
solubilized in 100 ml of 20mMdodecylmaltoside for 2 hr at 4C. The so-
lution was cleared by centrifugation, and fluorescence of the superna-
tant at 490–530 nm was measured in a Fluoromax-3 (Horiba) by GFP
excitation at 480nm. 3H-AMPAbindingmeasurementswereperformed
essentially as described previously (Armstrong and Gouaux, 2000).
Western Blotting
Three to five healthy oocytes per construct were tested for current and
selected for SDS-PAGE. Oocytes were lysed by pipetting in 30 ml/oo-
cyte of 20 mM Tris, pH 7.4, 100 mM NaCl, and 1% Triton X-100 plus
protease inhibitor cocktail (Sigma); sampleswere run on 10%acrylam-
ide gels analyzed by western blotting using an anti-GluR2/3 primary
antibody (Chemicon). Bands were visualized by chemiluminescence.
S1S2 Crystallization
The S729C and G725C mutations were incorporated into the S1S2J
construct (Armstrong and Gouaux, 2000) by PCR and the resulting
proteins were expressed and purified using methods described before
(Furukawa and Gouaux, 2003). Disulfide-bond formation was cata-
lyzed by 500–700 mM CuSO4 and 1.0–1.4 mM 1,10-phenanthroline.
Samples were incubated at 4C for 30 min and reactions were termi-
nated by addition of 3 mM EDTA. The quenched reaction mixture
was digested with trypsin and the desired dimer was isolated by ion
exchange and size-exclusion chromatography. The molecular mass
of the dimer was confirmed using SDS-PAGE and MALDI-TOF. The
proteins were dialyzed against 10 mM HEPES (pH 7.0), 20 mM NaCl,
1 mM EDTA, and 10 mM glutamate and concentrated to 10 mg/ml.
Crystals were grown by vapor diffusion at 4Cwith 1:1, 1:2, and 2:1 ra-
tio (v/v) of protein to reservoir solution (0.1 M cacodylate [pH 6.5], 18%
PEG 8K, and 20 mM zinc acetate). Prior to cryo-cooling with liquid ni-
trogen, crystals were soaked in reservoir buffer supplemented with
20% glycerol and 10 mM glutamate.
Structure Determination and Refinement
Data sets were collected at NSLS (X4A) and indexed, integrated, and
scaled with HKL2000 (see Tables S2 and S3). The S729C and
G725C structures were solved by molecular replacement (Navaza,
1994) using a single glutamate bound protomer (Protein Data Bank
ID code 1FTJ) as a search probe. Molecular replacement phases
were improved by density modification using DM (CCP4, 1994). Itera-
tive cycles of manual building, solvent addition, and crystallographic
refinement were carried out with O (Jones et al., 1991) and CNS
(Brunger et al., 1998) until the R/Rfree values converged.
Supplemental Data
Supplemental Data include two figures and three tables and can be
found with this article online at http://www.cell.com/cgi/content/full/
127/1/85/DC1/.
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